Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.09 USD | -1.56% |
|
-5.43% | +2.83% |
Feb. 12 | C Worldwide Healthcare Select up 5.8% in January - divests Illumina | FW |
Feb. 07 | Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing | MT |
Evolution of the Average Target: Vaxcyte, Inc.
Evolution of the Target Price: Vaxcyte, Inc.
Changes in Analyst Recommendations: Vaxcyte, Inc.
Consensus | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+75.47% | ||||||
+9.86% | ||||||
+40% | ||||||
+1.37% | ||||||
+24.59% | ||||||
+26.91% | ||||||
+15.12% | ||||||
+14.34% | ||||||
+68.77% | ||||||
+64.62% | ||||||
Average | +34.10% | |||||
Weighted average by Cap. | +24.10% |
Analysts' Consensus

Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
Mizuho Securities | |
Needham & Co. | |
TD Cowen | |
BofA Securities | |
Guggenheim | |
SVB Securities LLC | |
BTIG |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PCVX Stock
- Consensus Vaxcyte, Inc.